New advances in noninvasive screening technology for colorectal cancer

Ning Zhu; Ziyan Tong; Ying Yuan

doi:10.1002/mco2.70050

MedComm ›› 2025, Vol. 6 ›› Issue (1) : e70050 DOI: 10.1002/mco2.70050

HIGHLIGHT

New advances in noninvasive screening technology for colorectal cancer

Ning Zhu ¹^,²
, Ziyan Tong ¹^,²
, Ying Yuan ¹^,²^,³^,^†

Author information +

History +

PDF

Cite this article

Download citation ▾

Ning Zhu, Ziyan Tong, Ying Yuan. New advances in noninvasive screening technology for colorectal cancer. MedComm, 2025, 6(1): e70050 DOI:10.1002/mco2.70050

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Imperiale TF, Porter K, Zella J, et al. Next-generation multitarget stool DNA test for colorectal cancer screening. N Engl J Med. 2024; 390(11): 984-993.

[2]	Chung DC, Gray DM, Singh H, et al. A cell-free DNA blood-based test for colorectal cancer screening. N Engl J Med. 2024; 390(11): 973-983.

[3]	Ladabaum U, Dominitz JA, Kahi C, Schoen RE. Strategies for colorectal cancer screening. Gastroenterology. 2020; 158(2): 418-432.

[4]	Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014; 370(14): 1287-1297.

[5]	Potter NT, Hurban P, White MN, et al. Validation of a real-time PCR-based qualitative assay for the detection of methylated SEPT9 DNA in human plasma. Clin Chem. 2014; 60(9): 1183-1191.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.